|
Sign In to gain access to subscriptions and/or personal tools.
|
Multiple Sclerosis, Vol. 11, No. 1,
24-32 (2005)
DOI: 10.1191/1352458505ms1119oa
Multiple sclerosis and nutrition
Stefan Schwarz
Department of Neurology, Klinikum Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim 68135, Germany, s.schwarz{at}neuro.ma.uni-heidelberg.de
Hans Leweling
Department of Internal Medicine, Klinikum Mannheim of the University of Heidelberg, Theodor-Kutzer-Ufer 1-3, Mannheim 68135, Germany
Benefits from any particular diet in multiple sclerosis (MS) have not yet been proven. It is, however, frequent that malnutrition may potentially exacerbate the symptoms of MS. There is some evidence that a high intake of saturated fat increases the incidence of MS. Epidemiological studies imply that unsaturated fatty acids may have a positive effect on the course of MS. However, the results of controlled studies are ambiguous. A meta-analysis of three small controlled clinical trials suggests a benefit from linoleic acid. Intake of Vitamin D is associated with a lower incidence of MS. In MS, the risk of osteoporosis is high, and prophylactic vitamin D and calcium should be considered at an early stage. The role of minerals, trace elements, antioxidants, vitamins or fish oil is unclear. The possible relationships between diet and MS have not been subjected to adequate study. It seems possible that in the future, diets or dietary supplements may become recommended forms of treatment for MS.
Key Words: fatty acids multiple sclerosis nutrition vitamin D

CiteULike Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
L. Piccio, J. L. Stark, and A. H. Cross
Chronic calorie restriction attenuates experimental autoimmune encephalomyelitis
J. Leukoc. Biol.,
October 1, 2008;
84(4):
940 - 948.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S Schwarz, C Knorr, H Geiger, and P Flachenecker
Complementary and alternative medicine for multiple sclerosis
Multiple Sclerosis,
September 1, 2008;
14(8):
1113 - 1119.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
M Soilu-Hanninen, M Laaksonen, I Laitinen, J-P Eralinna, E-M Lilius, and I Mononen
A longitudinal study of serum 25-hydroxyvitamin D and intact parathyroid hormone levels indicate the importance of vitamin D and calcium homeostasis regulation in multiple sclerosis
J. Neurol. Neurosurg. Psychiatry,
February 1, 2008;
79(2):
152 - 157.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Lucas, A-L. Ponsonby, A. McMichael, I. van der Mei, C. Chapman, A. Coulthard, K. Dear, T. Dwyer, T. Kilpatrick, M. Pender, et al.
Observational analytic studies in multiple sclerosis: controlling bias through study design and conduct. The Australian Multicentre Study of Environment and Immune Function
Multiple Sclerosis,
August 1, 2007;
13(7):
827 - 839.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Stephenson, M. Brotherwood, R. Robert, E. Atenafu, M. Corey, and E. Tullis
Cholecalciferol significantly increases 25-hydroxyvitamin D concentrations in adults with cystic fibrosis
Am. J. Clinical Nutrition,
May 1, 2007;
85(5):
1307 - 1311.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lee, K. M. Gura, S. Kim, D. A. Arsenault, B. R. Bistrian, and M. Puder
Current Clinical Applications of {Omega}-6 and {Omega}-3 Fatty Acids
Nutr Clin Pract,
August 1, 2006;
21(4):
323 - 341.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|